Delhi HC Denies Bail To Accused Individuals

New Delhi:  The Delhi High Court, on Tuesday, denied bail to individuals accused of manufacturing and selling counterfeit cancer and chemotherapy drugs. The investigation exposed a network involving top hospitals, resulting in eight victims, including one fatality, and the seizure of over 140 vials of fake drugs valued at Rs 4 crore.

The bench of Justice Chandra Dhari Singh noted that ED presented, “Sufficient material to warrant judicial custody including statements of co-accused, electronic records etc. These materials suggest an active involvement in laundering proceeds of crime”.

During the hearing, the court remarked that the evidence strongly indicated the laundering of proceeds of crime, necessitating a thorough trial. The court further noted that the applicant failed to provide sufficient evidence to counter the allegations or justify the grant of bail.

Advocate for the State however informed the court that Aditya Krishna (one of the accused) is out on medical bail. Taking this into account, the court directed the accused to surrender within seven days, ensuring adherence to due process.

The investigation uncovered a significant scam involving counterfeit cancer medications. Victims of the scam included an Uzbekistan national who purchased six injections for Rs 5.92 lakh, a resident of Jammu and Kashmir who bought two injections for Rs 1.80 lakh, and a Haryana resident who acquired six injections for Rs 5.67 lakh. Other victims included a woman from Chandigarh who purchased ten injections for her mother at Rs 13.50 lakh, a Punjab resident who spent Rs 16.20 lakh on twelve injections for his mother, and another Chandigarh woman who paid Rs 13.50 lakh for ten injections for her grandmother.

The charge sheet also highlighted an incident in Madhubani, Bihar, where a man’s wife, suffering from mouth and lung cancer, deteriorated after receiving counterfeit Keytruda injections. Following treatment at the Rajiv Gandhi Cancer Institute and Buddha Cancer Hospital in Patna, the man purchased four injections for Rs 3.60 lakh from an online contact named Love Narula. After administering two injections, the patient’s health worsened, leading to her death on September 11, 2022.

In March, seven suspects were arrested by the Inter-State Cell of the Crime Branch in collaboration with the Delhi government’s Department of Drugs Control. This was followed by the apprehension of five more individuals. Delhi Police, therefore, filed a chargesheet against the accused before Tis Hazari Court in July 2024.

The investigation revealed that four of the accused worked in the oncology departments of leading cancer hospitals in Delhi and Gurgaon. Among them, two were pharmacists at the Rajiv Gandhi Cancer Institute, while others were associated with Fortis Memorial Research Institute, Millennium Cancer Center in Gurgaon, and Venkateshwar Hospital in Delhi.

Case Title: Aditya Krishna v Directorate Of Enforcement (BAIL APPLN.-3464/2024)

SOURCE : Law Beat

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert